Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,06118,080 of 20,252 grants

Completed NON-SBIR/STTR RPGS
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2021 – 2026

Kaposi?s sarcoma is an HIV/ AIDS associated malignancy that in spite of the implementation of ART causes significant morbidity and mortality.Pathogenesis based design and testing o...

$5.78M
USD
Completed NON-SBIR/STTR RPGS
Developmental therapy for selectively targeting MEK-ERK pathway in cancer cells and tumor stromal compartment
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2026

Project Summary/Abstract Carcinogenic mutations in the RAS-RAF-MEK-ERK pathway are present in 46% of all human cancers. This has inspired the successful development of many small m...

$4.29M
USD
Completed SBIR-STTR RPGS
Highly multiplexed live-cell GPCR arrays for drug discovery in glioma.
NATIONAL CANCER INSTITUTE Spectragenetics United States 2021 – 2022

Project summary/Abstract We will deploy an automated multiplexed live-cell assay to detect and quantify agonist and inverse-agonist activities against 55 GPCRs known to be upregula...

$2.23M
USD
Completed NON-SBIR/STTR RPGS
Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer
NATIONAL CANCER INSTITUTE University of Arizona United States 2021 – 2026

ABSTRACT It is well accepted that intrinsic action of the androgen receptor (AR) within the prostate epithelium drives prostate cancer proliferation and survival. Less appreciated...

$4.84M
USD
Completed NON-SBIR/STTR RPGS
Developmental therapy for selectively targeting MEK-ERK pathway in cancer cells and tumor stromal compartment
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2026

Project Summary/Abstract Carcinogenic mutations in the RAS-RAF-MEK-ERK pathway are present in 46% of all human cancers. This has inspired the successful development of many small m...

$4.37M
USD
Completed NON-SBIR/STTR RPGS
Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer
NATIONAL CANCER INSTITUTE University of Arizona United States 2021 – 2026

ABSTRACT It is well accepted that intrinsic action of the androgen receptor (AR) within the prostate epithelium drives prostate cancer proliferation and survival. Less appreciated...

$4.72M
USD
Completed NON-SBIR/STTR RPGS
Developmental therapy for selectively targeting MEK-ERK pathway in cancer cells and tumor stromal compartment
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2026

Project Summary/Abstract Carcinogenic mutations in the RAS-RAF-MEK-ERK pathway are present in 46% of all human cancers. This has inspired the successful development of many small m...

$4.43M
USD
Completed NON-SBIR/STTR RPGS
Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer
NATIONAL CANCER INSTITUTE University of Arizona United States 2021 – 2026

ABSTRACT It is well accepted that intrinsic action of the androgen receptor (AR) within the prostate epithelium drives prostate cancer proliferation and survival. Less appreciated...

$4.68M
USD
Completed NON-SBIR/STTR RPGS
Developmental therapy for selectively targeting MEK-ERK pathway in cancer cells and tumor stromal compartment
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2026

Project Summary/Abstract Carcinogenic mutations in the RAS-RAF-MEK-ERK pathway are present in 46% of all human cancers. This has inspired the successful development of many small m...

$4.26M
USD
Completed NON-SBIR/STTR RPGS
Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer
NATIONAL CANCER INSTITUTE University of Arizona United States 2021 – 2026

ABSTRACT It is well accepted that intrinsic action of the androgen receptor (AR) within the prostate epithelium drives prostate cancer proliferation and survival. Less appreciated...

$4.52M
USD
Completed NON-SBIR/STTR RPGS
Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2021 – 2026

PROJECT SUMMARY Anaplastic large cell lymphoma (ALCL) comprises a collection of mature T-cell neoplasms that share elevated expression of CD30 and anaplastic cytology. ALCL subtype...

$4.18M
USD
Completed OTHER RESEARCH-RELATED
Sustaining the Integrative Imaging Informatics for Cancer Research (I3CR) Center
NATIONAL CANCER INSTITUTE Washington University United States 2021 – 2026

Abstract Artificial intelligence (AI) and other computationally intensive methods have the potential to revolutionize cancer imaging research and patient care.The broad adoption of...

$7.7M
USD
Completed NON-SBIR/STTR RPGS
Evaluating a Novel Autophagy Inhibitor in KRAS-Driven Lung Cancer
NATIONAL CANCER INSTITUTE Michigan State University United States 2021 – 2023

PROJECT SUMMARY Autophagy is an intracellular recycling process controlled by the kinase ULK1 that is important in the survival and growth of KRAS mutant lung tumors.Our team and o...

$4.02M
USD
Completed TRAINING, INDIVIDUAL
Supplement to AWD32581 - Fritz fellowship F32CA220935
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2021

PROJECT SUMMARY No changes during requested extension period.

$173K
USD
Completed NON-SBIR/STTR RPGS
P53, DNA Repair Imbalance, and Immune Response in Breast Cancer Mortality Disparities
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Genome stability is determined by multiple DNA repair pathways, including both error-prone and error-free mechanisms. Mutations can be caused by inactivati...

$5.62M
USD
Completed NON-SBIR/STTR RPGS
P53, DNA Repair Imbalance, and Immune Response in Breast Cancer Mortality Disparities
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Genome stability is determined by multiple DNA repair pathways, including both error-prone and error-free mechanisms. Mutations can be caused by inactivati...

$5.97M
USD
Completed NON-SBIR/STTR RPGS
Targeting the metastasis initiating cell in undifferentiated pleomorphic sarcoma
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2026

Undifferentiated pleomorphic sarcoma (UPS) is a soft tissue sarcoma, with one of the worst prognosis.We will build on our discovery that UPS contains a small subpopulation of metas...

$4.86M
USD
Completed NON-SBIR/STTR RPGS
Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2021 – 2026

PROJECT SUMMARY Anaplastic large cell lymphoma (ALCL) comprises a collection of mature T-cell neoplasms that share elevated expression of CD30 and anaplastic cytology. ALCL subtype...

$3.83M
USD
Completed OTHER RESEARCH-RELATED
Sustaining the Integrative Imaging Informatics for Cancer Research (I3CR) Center
NATIONAL CANCER INSTITUTE Washington University United States 2021 – 2026

Abstract Artificial intelligence (AI) and other computationally intensive methods have the potential to revolutionize cancer imaging research and patient care. The broad adoption o...

$8.02M
USD
Completed NON-SBIR/STTR RPGS
Targeting the metastasis initiating cell in undifferentiated pleomorphic sarcoma
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2026

Undifferentiated pleomorphic sarcoma (UPS) is a soft tissue sarcoma, with one of the worst prognosis. We will build on our discovery that UPS contains a small subpopulation of meta...

$4.26M
USD